Considerations for Medication Management and Anticoagulation During Continuous Renal Replacement Therapy

Area of Science:

• Pharmacology
• Nephrology
• Critical Care Medicine

Background:

• Critically ill patients often require continuous renal replacement therapy (CRRT).
• Drug dosing and monitoring during CRRT are complex due to limited pharmacokinetic data in acute kidney injury.
• Understanding drug clearance in CRRT is crucial for safe and effective patient care.

Purpose of the Study:

• To review the principles of drug clearance during CRRT.
• To examine factors influencing medication management in patients undergoing CRRT.
• To discuss available evidence for drug dosing and anticoagulation strategies in CRRT.

Main Methods:

• Review of existing literature on drug pharmacokinetics and pharmacodynamics in acute kidney injury and CRRT.
• Analysis of CRRT modalities and their impact on drug removal.
• Evaluation of published studies on drug disposition and clinical outcomes during CRRT.
• Compilation of current anticoagulation strategies for CRRT circuits.

Main Results:

• Drug clearance during CRRT is influenced by drug properties (e.g., molecular weight, protein binding) and CRRT parameters (e.g., filter type, flow rates).
• Limited evidence exists for specific drug dosing recommendations, necessitating a principles-based approach.
• Various anticoagulation strategies can be employed to maintain CRRT circuit patency.

Conclusions:

• Effective medication management in CRRT requires a thorough understanding of drug properties and CRRT system interactions.
• Further research is needed to establish robust, evidence-based dosing guidelines for commonly used medications during CRRT.
• Appropriate anticoagulation is essential for the successful and continuous delivery of CRRT.